An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom.
- DOI
- 10.1007/s40261-024-01363-1
- Published
- 2024 Jun
- Container
- Clinical drug investigation
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s40261-024-01363-1,
title = {An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom.},
author = {Bretos-Azcona PE and Wallace M and Jootun M and Jin G and Agirrezabal I and Szende A},
year = {2024},
journal = {Clinical drug investigation},
doi = {10.1007/s40261-024-01363-1},
url = {https://doi.org/10.1007/s40261-024-01363-1}
}RIS
TY - JOUR TI - An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom. AU - Bretos-Azcona PE AU - Wallace M AU - Jootun M AU - Jin G AU - Agirrezabal I AU - Szende A PY - 2024 JO - Clinical drug investigation DO - 10.1007/s40261-024-01363-1 UR - https://doi.org/10.1007/s40261-024-01363-1 ER -
APA
PE, B., M, W., M, J., G, J., I, A., & A, S. (2024). An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom.. Clinical drug investigation. https://doi.org/10.1007/s40261-024-01363-1
Source records
- pubmed · retrieved 2026-09-26T13:58:02.018Z